Clinical Trials Logo
  1. Home
  2. Kidney Failure, Chronic
  3. NCT05399420

Study of Kidney Circulating Cell-free DNA in Patients With Acute Kidney Failure — ADNIRA  

Kidney Failure, Acute Clinical Trial

Official title:
Study of the Quantitative Evolution of Circulating Cell-free DNA of Renal Origin in Patients With Acute Renal Failure

Clinical Trial Summary

The amount of total circulating DNA has been shown to increase in patients with acute renal failure. Nevertheless, it is currently not currently possible to prove the renal origin of this circulating DNA. Recently, in healthy subjects, teams have shown that it is possible to identify its tissue origin of circulating DNA. CGenetix is a MedTech company which develops on an identical principle an in vitro diagnostic test capable of identifying and quantifying renal degradation during an acute trauma. The objective of this study is to evaluate the sensitivity of the proposed technology to detect circulating DNA of renal origin released into the general circulation in patients with acute organic and functional renal failure. Patients with functional or organic kidney deficiency will be included and the kidney biomarkers develop by CGenetix will be compared between these 2 groups of patients.

Clinical Trial Description

When the patient arrives, a first stage of checking the inclusion/non-inclusion criteria will be respected. Patients who do not meet the eligibility criteria will not be sampled (pre-screening stage). Patients meeting the eligibility criteria will be informed of the study by the investigator and a written information note will be given to them. If they do not object to their participation, an additional tube of blood for research purposes will be taken during a blood sample taken as soon as they are admitted as part of their usual treatment. They will also follow the standard care protocol according to the clinical recommendations of their attending physician. The objective of early sampling is to sensitize the test by assaying the marker as soon as possible after renal injury. In the event of a posteriori differential diagnosis (obstructive ARF or IRC), the patient will be excluded from the final analysis. Patients passing the pre-screening and screening stages positively will be included in the final analysis. 90 patients should be included and divided into 2 groups: - 65 patients with non-biopsied organic acute kidney injury of which 20 patients with biopsied organic acute kidney injury (test group) - 25 patients with functional acute kidney failure (control group). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05399420
Study type Observational
Source CGenetix
Contact Geoffroy Poulet, PhD
Phone +33667772394
Email geoffroy.poulet@cgenetix.com
Status Not yet recruiting
Phase
Start date September 10, 2022
Completion date January 10, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT00982527 - Fenoldopam in Pediatric Cardiac Surgery Phase 3
Completed NCT00908843 - Prevention of Contrast Induced Nephropathy (NIC) by Intravenous Versus Oral Rehydration N/A
Completed NCT00654992 - Effect of Erythropoietin (EPO) in Kidney After Cardiac Surgery Phase 2/Phase 3
Completed NCT05407272 - Explore the Sharing Model Intervene to Improve the Knowledge, Attitudes, Service Intentions and Service Start-up Effects of the Eight Major Non-cancer Disease End-stage Caregivers on Well-being and Palliative Care N/A
Recruiting NCT04334707 - Kidney Precision Medicine Project
Completed NCT04072432 - A Study of RBT-3 in Healthy Volunteers and Volunteers With Stage 3-4 Chronic Kidney Disease Phase 1
Recruiting NCT00230412 - Study of Heat Shock Proteins as Prognostic Factor of Acute Renal Failure in Children (HSP-Study) N/A
Completed NCT00148044 - Uremic Toxins of Patients With Acute Kidney Failure N/A
Active, not recruiting NCT04450095 - Effects of Endothelin Receptor Antagonist on Ischemic Kidney Injury During Nephron Sparing Surgery Phase 2
Terminated NCT05747053 - Personalization of Immunosuppressive Treatment for Organ Transplant Recipients
Completed NCT03353389 - Review of Trend in Incidence and Characteristics of Hospital-acquired Acute Kidney Injury in Hospital Selayang
Completed NCT03727581 - Ultrasound for Guidewire Detection
Completed NCT00912184 - Study Comparing High Cut-off Haemofiltration With Standard Haemofiltration in Acute Renal Failure Phase 1/Phase 2
Recruiting NCT00522756 - Preventing Acute Renal Failure After Cardiac Surgery in High Risk Patients Using Sodium Bicarbonate Therapy Phase 3
Completed NCT00484354 - Use of Bicarbonate to Reduce the Incidence of Acute Renal Failure After Cardiac Surgery Phase 2
Terminated NCT00316576 - Angiotensin-Converting Enzyme Polymorphism and Acute Renal Failure (ECAREA) N/A
Completed NCT00122018 - An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents for Cardiac Surgery Phase 2
Unknown status NCT01359722 - N-acetylcysteine to Prevent Renal Failure N/A
Completed NCT00286273 - Safety and Efficacy of the Use of Regional Anticoagulation With Citrate in Continuous Venovenous Hemofiltration Phase 4
Completed NCT03476460 - Sodium Chloride and Contrast Nephropathy Phase 2